These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 18855277)

  • 1. [Efficacy and safety of intravitreal injection of bevacizumab in the treatment of neovascular glaucoma: systematic review].
    Martínez-Carpio PA; Bonafonte-Márquez E; Heredia-García CD; Bonafonte-Royo S
    Arch Soc Esp Oftalmol; 2008 Oct; 83(10):579-88. PubMed ID: 18855277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases.
    Wakabayashi T; Oshima Y; Sakaguchi H; Ikuno Y; Miki A; Gomi F; Otori Y; Kamei M; Kusaka S; Tano Y
    Ophthalmology; 2008 Sep; 115(9):1571-80, 1580.e1-3. PubMed ID: 18440643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal bevacizumab and aqueous shunting surgery for neovascular glaucoma: safety and efficacy.
    Eid TM; Radwan A; el-Manawy W; el-Hawary I
    Can J Ophthalmol; 2009 Aug; 44(4):451-6. PubMed ID: 19606170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of intravitreal bevacizumab in neovascular glaucoma.
    Gheith ME; Siam GA; de Barros DS; Garg SJ; Moster MR
    J Ocul Pharmacol Ther; 2007 Oct; 23(5):487-91. PubMed ID: 17900231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of intravitreal bevacizumab on iris vessels in neovascular glaucoma patients.
    Sugimoto Y; Mochizuki H; Okumichi H; Takumida M; Takamatsu M; Kawamata S; Kiuchi Y
    Graefes Arch Clin Exp Ophthalmol; 2010 Nov; 248(11):1601-9. PubMed ID: 20524132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of treatment of neovascular glaucoma with intravitreal bevacizumab.
    Moraczewski AL; Lee RK; Palmberg PF; Rosenfeld PJ; Feuer WJ
    Br J Ophthalmol; 2009 May; 93(5):589-93. PubMed ID: 19074917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravitreal bevacizumab (Avastin) injection for neovascular glaucoma: a survey on 23 cases throughout 12-month follow-up.
    Costagliola C; Cipollone U; Rinaldi M; della Corte M; Semeraro F; Romano MR
    Br J Clin Pharmacol; 2008 Nov; 66(5):667-73. PubMed ID: 19032174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous intravitreal and intracameral injection of bevacizumab (Avastin) in neovascular glaucoma.
    Yuzbasioglu E; Artunay O; Rasier R; Sengul A; Bahcecioglu H
    J Ocul Pharmacol Ther; 2009 Jun; 25(3):259-64. PubMed ID: 19348598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal bevacizumab for neovascular glaucoma.
    Andrijević-Derk B; Vatavuk Z; Bencić G; Novak-Laus K; Mandić Z
    Acta Clin Croat; 2008 Sep; 47(3):175-9. PubMed ID: 19175068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal bevacizumab for neovascular glaucoma: a randomized controlled trial.
    Yazdani S; Hendi K; Pakravan M; Mahdavi M; Yaseri M
    J Glaucoma; 2009; 18(8):632-7. PubMed ID: 19826393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal bevacizumab for the treatment of neovascular glaucoma associated with central retinal artery occlusion.
    Sagong M; Kim J; Chang W
    Korean J Ophthalmol; 2009 Sep; 23(3):215-8. PubMed ID: 19794952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined diode laser cyclophotocoagulation and intravitreal bevacizumab (Avastin) in neovascular glaucoma.
    Ghosh S; Singh D; Ruddle JB; Shiu M; Coote MA; Crowston JG
    Clin Exp Ophthalmol; 2010 May; 38(4):353-7. PubMed ID: 20665941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of intravitreal bevacizumab in eyes with neovascular glaucoma undergoing Ahmed glaucoma valve implantation: 2-year follow-up.
    Arcieri ES; Paula JS; Jorge R; Barella KA; Arcieri RS; Secches DJ; Costa VP
    Acta Ophthalmol; 2015 Feb; 93(1):e1-6. PubMed ID: 24989855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal bevacizumab as an adjunct treatment for neovascular glaucoma.
    Hasanreisoglu M; Weinberger D; Mimouni K; Luski M; Bourla D; Kramer M; Robinson A; Axer-Siegel R
    Eur J Ophthalmol; 2009; 19(4):607-12. PubMed ID: 19551676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intravitreal bevacizumab in the treatment of neovascular glaucoma].
    Ouhadj O; Chergui I; Mendil L; Nouri MT
    J Fr Ophtalmol; 2009 Feb; 32(2):112-6. PubMed ID: 20579473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal bevacizumab for neovascular glaucoma.
    Jonas JB; Golubkina L; Libondi T; Rensch F
    Acta Ophthalmol; 2010 Mar; 88(2):e22-3. PubMed ID: 19519731
    [No Abstract]   [Full Text] [Related]  

  • 17. The use of intravitreal bevacizumab in neovascular glaucoma: a case report.
    Kelkar AS; Kelkar SB; Kelkar JA; Nagpal M; Patil SP
    Bull Soc Belge Ophtalmol; 2007; (303):43-5. PubMed ID: 17894286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid improvement of retinal and iris neovascularization after a single intravitreal bevacizumab injection in a patient with central retinal vein occlusion and neovascular glaucoma.
    Batioğlu F; Astam N; Ozmert E
    Int Ophthalmol; 2008 Feb; 28(1):59-61. PubMed ID: 17609852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjunctive intravitreal bevacizumab-combined trabeculectomy versus trabeculectomy alone in the treatment of neovascular glaucoma.
    Chen CH; Lai IC; Wu PC; Chen YJ; Chen YH; Lee JJ; Liu YC; Kuo HK
    J Ocul Pharmacol Ther; 2010 Feb; 26(1):111-8. PubMed ID: 20148654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal bevacizumab in refractory neovascular glaucoma: a prospective, observational case series.
    Kotecha A; Spratt A; Ogunbowale L; dell'Omo R; Kulkarni A; Bunce C; Franks WA
    Arch Ophthalmol; 2011 Feb; 129(2):145-50. PubMed ID: 21320957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.